ProfileGDS4459 / ENSG00000179776
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 46% 56% 73% 78% 65% 59% 76% 66% 66% 72% 58% 66% 63% 64% 66% 59% 67% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.346
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.6156
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.6373
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.778
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.0565
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.7559
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.8976
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.1466
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.1366
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.5172
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.5958
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.1466
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.9763
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.9264
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.1766
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.759
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.0367